The Journal of Organic Chemistry
Article
4.16 (dd, J = 4.1, 12.8 Hz, 0.95H, H6A), 4.01 (ddd, J = 2.3, 4.1, 10.4
Hz, 0.95H, H5A), 3.98 (m, 0.05H, H6B), 3.97 (dd, J = 2.3, 12.8 Hz,
0.95H, H6A), 3.75 (ddd, J = 2.1, 4.4, 10.1 Hz, 0.05H, H5B), 2.06−1.91
(m, 13H, C(O)CH3, OH); 13C{1H} NMR (CDCl3, 75 MHz): δ
(ppm) 170.5 (C(O)CH3B), 170.1 (C(O)CH3A), 169.9 (C(O)CH3A),
169.5 (C(O)CH3A), 169.3 (C(O)CH3B), 169.1 (C(O)CH3A), 168.8
(C(O)CH3B), 168.6 (C(O)CH3B), 91.6 (C1B), 88.9 (C1A), 72.63
(C3B), 72.56 (C5B), 70.1 (C2B), 69.7 (C3A, C5A), 69.1 (C2A, C6B), 67.8
(C4A), 67.6 (C4B), 61.4 (C6B), 20.8−20.3 (C(O)CH3).
dried over anhydrous Na2SO4, and concentrated under vacuum. The
crude product was purified by chromatography over silica gel
(EtOAc/MeOH, 95:5) to give 12 (78 mg, 47%) as a colorless oil.
1H NMR (CDCl3, 300 MHz): δ (ppm) 5.77 (d, J = 8.9 Hz, 1H, H1),
5.30 (dd, J = 10.6, 9.5 Hz, 1H, H3), 5.03 (t, J = 9.5 Hz, 1H, H4), 4.59
(d, J = 9.5 Hz, 1H, H2), 3.90 (m, 1H, H5), 3.75 (dd, J = 12.5, 3.5 Hz,
1H, H6), 3.65−3.47 (m, 6H, OCH3, H6, NH, OH), 2.05 (s, 3H,
CH3CO), 2.04 (s, 3H, CH3CO), 1.95 (s, 3H, CH3C(O)NH);
13C{1H} NMR (CDCl3, 75 MHz): δ (ppm) 171.1 (NHC(O)CH3),
170.5 (C(O)CH3), 170.2 (C(O)CH3), 101.7 (C1), 74.0 (C2), 72.3,
(C5) 68.9 (C4), 61.3 (C3), 56.8 (C6), 54.5 (OCH3), 23.3 (C(O)
CH3), 20.8 (C(O)CH3), 20.7 (C(O)CH3).
Compounds 10/10′. To a solution of the corresponding
peracetylated substrate (143 mg, 0.526 mmol) and Cp2ZrCl2 (46
mg, 0.158 mmol) in dry THF (2.5 mL), DIBAL-H (1 M in THF, 2.1
mL, 2.1 mmol, 1.5 mL/h) was added dropwise via a syringe pump at
−40 °C. After the end of the addition, the reaction mixture was
diluted with DCM (5 mL), quenched with 1 M citric acid solution (4
mL), and stirred for few seconds until a clear biphasic mixture is
obtained. The aqueous phase was extracted with DCM (3 × 5 mL).
The organic phases were combined, washed with 1 M aq HCl solution
(5 mL), dried over anhydrous Na2SO4, and concentrated under
vacuum. The crude product was purified by chromatography over
silica gel (cyclohexane/EtOAc 1:1) to give 10/10′ (83 mg, 69%) as
Compound 13. To a solution of the corresponding peracetylated
substrate (164 mg, 0.541 mmol) and Cp2ZrCl2 (48 mg, 0.162 mmol)
in dry THF (2.5 mL), DIBAL-H (1 M in THF, 1.6 mL, 1.6 mmol, 1.5
mL/h) was added dropwise via a syringe pump at −20 °C. After the
end of the addition, the reaction mixture was diluted with DCM (5
mL), quenched with 1 M citric acid solution (4 mL), and stirred for
few seconds until a clear biphasic mixture is obtained. The aqueous
phase was extracted with DCM (3 × 5 mL). The organic phases were
combined, washed with 1 M aq HCl solution (5 mL), dried over
anhydrous Na2SO4, and concentrated under vacuum. The crude
product was purified by chromatography over silica gel (petroleum
1
an inseparable mixture. H NMR (CDCl3, 300 MHz): δ (ppm) 6.45
(dd, J = 1.3, 6.0 Hz, 0.92H, H1A), 6.37 (dd, J = 0.9, 6.1 Hz, 0.08H,
H1B), 5.41 (ddd, J = 1.3, 2.4, 6.2 Hz, 0.92H, H3A), 5.18 (dd, J = 6.2,
8.9 Hz, 0.92H, H4A), 4.95 (dd, J = 5.8, 8.8 Hz, 0.08H, H4B), 4.83 (dd,
J = 2.8, 6.1 Hz, 0.08H, H2B), 4.77 (dd, J = 2.4, 6.0 Hz, 0.92H, H2A),
4.38 (dd, J = 5.4, 12.2 Hz, 0.08H, H6B), 4.28 (ddd, J = 0.9, 2.8, 5.8 Hz,
0.08H, H3B), 4.21 (dd, J = 2.5, 12.2 Hz, 0.08H, H6B), 4.10 (ddd, J =
2.5, 5.4, 8.8 Hz, 0.08H, H5B), 3.99 (ddd, J = 3.0, 4.6, 8.9 Hz, 0.92H,
H5A), 3.76 (dd, J = 3.0, 12.8 Hz, 0.92H, H6A), 3.69 (dd, J = 4.6, 12.8
Hz, 0.92H, H6A), 2.59 (br s, 0.08H, OHB), 2.38 (br s, 0.92H, OHA),
2.11 (s, 0.24H, C(O)CH3B), 2.09 (s, 2.76H, C(O)CH3A), 2.07 (s,
0.24H, C(O)CH3B), 2.03 (s, 2.76H, C(O)CH3A); 13C{1H} NMR
(CDCl3, 75 MHz): δ (ppm) 171.0 (2 × C(O)CH3B), 170.6 (2 ×
C(O)CH3A), 145.8 (C1A), 144.0 (C1B), 102.9 (C2B), 99.1 (C2A), 76.6
(C5A), 74.0 (C5B), 71.6 (C4B), 68.4 (C3A), 67.8 (C4A), 67.1 (C3B),
61.9 (C6B), 60.6 (C6B), 21.1 (C(O)CH3A), 21.0 (C(O)CH3A), 20.9
(C(O)CH3A), 20.8 (C(O)CH3B).
Compound 11. To a solution of the corresponding peracetylated
substrate (176 mg, 0.510 mmol) and Cp2ZrCl2 (45 mg, 0.153 mmol)
in dry THF (2.5 mL), DIBAL-H (1 M in THF, 1.75 mL, 1.75 mmol,
1.5 mL/h) was added dropwise via a syringe pump at −20 °C. After
the end of the addition, the reaction mixture was diluted with DCM
(5 mL), quenched with 1 M citric acid solution (4 mL), and stirred
for few seconds until a clear biphasic mixture is obtained. The
aqueous phase was extracted with DCM (3 × 5 mL). The organic
phases were combined, washed with 1 M aq HCl solution (5 mL),
dried over anhydrous Na2SO4, and concentrated under vacuum. The
crude product was purified by chromatography over silica gel
(cyclohexane/EtOAc 1:1) to give 11 (122 mg, 79%). 1H NMR
(CDCl3, 400 MHz): δ (ppm) 5.46 (dd, J = 9.4, 8.9 Hz, 0.66H, H3A),
4.85−4.78 (m, 1H, H3B, H1A), 4.49−4.43 (m, 1H, H1B, H4A), 4.38−
4.25 (m, 1.30H, H6A, H5B, H4B), 3.83 (ddd, J = 9.6, 4.7, 2.0 Hz, 0.66H,
H5A), 3.58 (s, 1H, OMeB), 3.56−3.45 (m, 1H,, H2A, H6B), 3.44 (s, 2H,
OMeA), 3.43−3.28 (m, 1.3H, H6B, H2B, H6A), 3.09 (d, J =3.4 Hz,
0.66H, OHA), 3.00 (d, J =5.3 Hz, 0.34H, OHB), 2.08−1.93 (m, 6H,
C(O)CH3); 13C{1H} NMR (CDCl3, 75 MHz): δ (ppm) 170.7
(C(O)CH3), 170.4 (C(O)CH3), 170.3 (C(O)CH3), 170.0 (C(O)
CH3), 102.8 (C1), 98.8 (C1), 73.9 (C2), 72.3 (C5), 70.1 (C2), 69.5
(C5), 68.9 (C4), 68.6 (C4), 63.8 (C3), 61.1 (C3), 61.0 (C6), 60.8 (C6),
57.4 (OCH3), 55.5 (OCH3), 20.7 + 20.6 + 20.6 (4 × C(O)CH3).
Compound 12. To a solution of the corresponding peracetylated
substrate (187 mg, 0.518 mmol) and Cp2ZrCl2 (45 mg, 0.155 mmol)
in dry THF (2.5 mL), DIBAL-H (1 M in THF, 1.55 mL, 1.55 mmol,
1.5 mL/h) was added dropwise via a syringe pump at −20 °C. After
the end of the addition, the reaction mixture was diluted with DCM
(5 mL), quenched with 1 M citric acid solution (4 mL), and stirred
for few seconds until a clear biphasic mixture is obtained. The
aqueous phase was extracted with DCM (3 × 5 mL). The organic
phases were combined, washed with 1 M aq HCl solution (5 mL),
1
ether/EtOAc 4:1) to give 13 (124 mg, 88%) as a colorless oil. H
NMR (CDCl3, 300 MHz): δ (ppm) 5.47 (bs, 1H), 4.24 (bs, 1H),
3.89 (dd, J = 4.0 Hz, J = 6.1 Hz, 2H), 2.73 (d, J = 4.8 Hz, 1H), 1.48
(s, 9H), 1.45 (s, 9H); 13C{1H} NMR (CDCl3, 75 MHz): δ (ppm)
169.8, 155.8, 82.5, 80.1, 63.9, 56.3, 28.3, 27.9; [α]D20 = −23 (CHCl3,
c = 0.5).
Compound 14. To a solution of the corresponding peracetylated
substrate (198 mg, 0.376 mmol) and Cp2ZrCl2 (33 mg, 0.112 mmol)
in dry THF (2 mL), DIBAL-H (1 M in THF, 1.1 mL, 1.1 mmol, 1.5
mL/h) was added dropwise via a syringe pump at −20 °C. After the
end of the addition, the reaction mixture was diluted with DCM (5
mL), quenched with 1 M citric acid solution (4 mL), and stirred for
few seconds until a clear biphasic mixture is obtained. The aqueous
phase was extracted with DCM (3 × 5 mL). The organic phases were
combined, washed with 1 M aq HCl solution (5 mL), dried over
anhydrous Na2SO4, and concentrated under vacuum. The crude
product was purified by chromatography over silica gel (petroleum
1
ether/EtOAc 95:5) to give 14 (130 mg, 71%) as a colorless oil. H
NMR (CDCl3, 300 MHz): δ (ppm) 4.60 (s, 1H), 4.51 (s, 1H), 4.40
(dd, J = 9.6, 6.6 Hz, 1H), 3.72 (d, J = 10.9 Hz, 1H), 3.25 (d, J = 10.9
Hz, 1H), 2.39.2.25 (m, 1H), 1.97 (s, 3H), 1.93−1.72 (m, 3H), 1.65−
0.86 (m, 32H), 0.80−0.73 (m, 9H); 13C{1H} NMR (CDCl3, 75
MHz): δ (ppm) 171.2, 150.6, 109.9, 81.1, 60.7, 55.5, 50.5, 48.9, 47.95,
47.93, 42.9, 41.1, 38.5, 37.9, 37.4, 37.2, 34.3, 34.1, 29.9, 29.3, 28.1,
27.2, 25.3, 23.8, 21.5, 21.0, 19.2, 18.3, 16.6, 16.3, 16.1, 14.9.
Site-Selective De-O-acetylation of 3 in Toluene. A mixture of
Cp2ZrCl2 (163 mg, 0.56 mmol) and of a 1.5 M solution of DIBAL-H
in toluene (1.5 mL, 2.24 mmol) in dry toluene (2 mL) was stirred at
−20 °C for 10 min. After addition of a solution of 3 (185 mg, 0.51
mmol) in dry toluene (1 mL), the reaction mixture was stirred for 30
min at this temperature. CH2Cl2 (5 mL) and a 1 M citric acid solution
(4 mL) were then added. After vigorous stirring for a few minutes, a
clear biphasic mixture was obtained. The aqueous phase was extracted
with CH2Cl2 (3 × 5 mL). The organic phases were combined, washed
with 1 M aq HCl solution (5 mL), dried over anhydrous Na2SO4, and
concentrated under vacuum. The crude product was purified by
chromatography over silica gel (cyclohexane/EtOAc 1:2) to give 4
(87 mg, 73%) as a white solid.
ASSOCIATED CONTENT
■
sı
* Supporting Information
The Supporting Information is available free of charge at
1
Detailed DFT calculations and H and 13C{1H} NMR
spectra of compounds 2 and 4−14 (PDF)
9287
J. Org. Chem. 2021, 86, 9280−9288